Back to the future with intravenous diuretics. Reinvigorating an old treatment through new care settings

JACC: Heart Failure

Volumn 4, Issue 1, 2016, Pages 9-11

  Eapen, Zubin J ^a   Kelly, Jacob P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ambulatory treatment; Heart failure; Intravenous diuretics; Loop diuretics

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

COST CONTROL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG USE; HEART FAILURE; HOSPITALIZATION; HUMAN; NOTE; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; INTRAVENOUS DRUG ADMINISTRATION;

DIURETICS; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS;

EID: 84951779806     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.07.016     Document Type: Editorial

References (12)

1. Greger R. Loop diuretics. Diuretics 1995, 221-274. Springer, Berlin Heidelberg. R. Greger, H. Knauf, E. Mutschler (Eds.).
2. Pizzi RA. Developing diuretics. Modern Drug Discovery, February 2003. Available at: . Accessed July 29, 2015. http://pubs.acs.org/subscribe/archive/mdd/v06/i02/pdf/203timeline.pdf.
3. Buckley L.F., Carter D.M., Matta L., et al. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. J Am Coll Cardiol HF 2016, 4:1-8.
4. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
5. Ross J.S., Chen J., Lin Z., et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010, 3:97-103.
6. Ryder M., Murphy N.F., McCaffrey D., O'Loughlin C., Ledwidge M., McDonald K. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail 2008, 10:267-272.
7. Makadia S., Simmons T., Augustine S., et al. The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure. Am J Med 2015, 128:527-531.
8. Feltner C., Jones C.D., Cene C.W., et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med 2014, 160:774-784.
9. Whellan D.J., Gaulden L., Gattis W.A., et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 2001, 161:2223-2228.
10. DeVore A.D., Allen L.A., Eapen Z.J. Thinking outside the box: treating acute heart failure outside the hospital to improve care and reduce admissions. J Card Fail 2015, 21:667-673.
11. Mentz R.J., Buggey J., Fiuzat M., et al. Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. J Cardiovasc Pharmacol 2015, 65:438-443.
12. Verma A.K., da Silva J.H., Kuhl D.R. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. Ann Pharmacother 2004, 38:544-549.